Safety of unoprostone isopropyl 0.15% ophthalmic solution in patients with mild to moderate asthma.

Purpose: To assess the safety of unoprostone isopropyl 0.15% ophthalmic solution (UIOS) in patients with mild to moderate asthma.

Methods: Randomized, double-masked, two-period crossover, placebo-controlled study comparing unoprostone 0.